Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide Plus Rituximab in Untreated Mantle Cell Lymphoma
NCT01472562Phase 2Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Jul 2011
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in mantle cell lymphoma (MCL), sponsored by Weill Cornell Medicine. Started Jul 2011; status: completed.
02
Drugs
lenalidomide
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT01472562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01472562.